1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Enteral Feeding Intolerance: new trials by email Literature Review of Enteral Feeding Intolerance trials Research Report on Enteral Feeding Intolerance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI) TAK-954, Metoclopramide, Normal Saline - Critical Illness, Enteral Nutrition | Phase 2 | Terminated | Millennium Pharmaceuticals, Inc. | 1 | 2018-08-25 | 2019-09-24 |
Critical Illness (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Metoclopramide (1) · Saline Solution (1)
Millennium Pharmaceuticals, Inc. (1)
Australia (1) · Canada (1) · United Kingdom (1) · United States (1)
2017 (1)